Login / Signup

Combined use of Anlotinib with chemotherapy in patients with advanced ovarian cancer: a real-world cohort study and meta-analysis.

XinYi HongShanHu QiuBo DingHao XuYang Shen
Published in: Therapeutic advances in medical oncology (2024)
The combined use of Anlotinib with chemotherapy showed potential in treating patients with advanced ovarian cancer, with a tolerable safety profile.
Keyphrases
  • locally advanced
  • radiation therapy
  • rectal cancer
  • chemotherapy induced
  • climate change